Cardio Diagnostics Holdings, Inc. Research And Development Expense

Quick Answer

Cardio Diagnostics Holdings, Inc. reported Research And Development Expense of $641.2 thousand for the year ending 2025.

  • Cardio Diagnostics Holdings, Inc. showed an increase of +181.3% in Research And Development Expense from 2024 to 2025.
  • This data is from Cardio Diagnostics Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
  • XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2021 to 2025), Cardio Diagnostics Holdings, Inc.'s Research And Development Expense has grown by 1,937.7%.
  • Historical annual values: Fiscal year 2025: $641.2 thousand | Fiscal year 2024: $228.0 thousand | Fiscal year 2023: $145.2 thousand | Fiscal year 2022: $40.4 thousand | Fiscal year 2021: $31.5 thousand.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: